Metronomic scheduling of trofosfamide chemotherapy in human NSCLC xenografts highly increases therapeutic efficacy compared to conventional scheduling by inhibition of angiogenesis.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples